Browse the evidence

Higher plasma TMAO levels are associated with higher abundance of Prevotella and Peptococcaceae, and lower abundance of Faecalibacterium prausnitzii, linking gut microbiota to a metabolite associated with cardiovascular risk.

TMAO, a metabolite linked to heart disease risk, is produced by gut bacteria from dietary components. Your gut bacteria composition affects your TMAO levels. Maintaining a healthy microbiome through a diverse diet may help manage TMAO levels, but this is one factor among many for cardiovascular health.

Activation of SIRT1 (via fasting or chemical activators like SRT1720/SRT2183) directly deacetylates SREBP transcription factors, leading to their ubiquitination, decreased protein stability, and rapid degradation, thereby inhibiting lipid and cholesterol synthesis.

Fasting or using SIRT1-activating compounds (like resveratrol or specific activators studied in the paper) can inhibit the production of fats and cholesterol by directly targeting the SREBP proteins responsible for fat synthesis. This happens through a process where SIRT1 removes acetyl groups from SREBP, marking it for destruction, thereby reducing lipid storage.

In utero exposure to undernutrition (famine) increases susceptibility to increased adiposity and disrupted glucose homeostasis in female offspring, whereas male offspring are more susceptible to neurological damage and decreased brain volume.

If you are pregnant or planning pregnancy, be aware that your baby's sex influences how early nutritional stress (like famine or severe restriction) affects them. Female fetuses are more likely to develop metabolic issues (obesity/diabetes risk) if exposed to undernutrition, while male fetuses are more vulnerable to neurological damage. This suggests that optimal maternal nutrition is critical for both, but the specific risks differ by sex.

In utero exposure to overnutrition (maternal obesity/high sugar) increases susceptibility to increased adiposity and disrupted glucose homeostasis in female offspring, whereas male offspring are more susceptible to changes in adiposity and body weight in some models, or hypothalamic inflammation.

Maternal obesity and high-sugar diets during pregnancy program offspring for metabolic disease differently based on sex. Female offspring are particularly at risk for glucose homeostasis disruption and adiposity. This underscores the importance of managing maternal metabolic health before and during pregnancy, with awareness that the risks manifest differently in boys and girls.

Actigraphy has very low specificity (approx. 50%) for detecting wakefulness during sleep, leading to significant overestimation of total sleep time and sleep efficiency, particularly in conditions with fragmented sleep or high wake propensity.

Do not rely on actigraphy (wrist-worn trackers) to assess your sleep quality if you have insomnia, sleep apnea, or shift work. These devices will likely overestimate how much you slept because they mistake lying still while awake for sleep. Use them for general trends, but not for clinical decision-making or detailed sleep analysis.

Administration of recombinant GDF15 reduces body weight and improves insulin sensitivity in obese models by increasing energy expenditure, lipid mobilization, and fatty acid oxidation in liver, muscle, and adipose tissue.

This research identifies GDF15 as a potent signal that triggers fat burning and energy use. While not a current supplement, it highlights that improving mitochondrial health in muscle may naturally boost this hormone, aiding weight management.

Self-reported sleep duration and quality using brief epidemiological questionnaires (1-3 items) show poor agreement with objective actigraphy measures, rendering them invalid for assessing sleep as a precise risk factor in large-scale studies.

If you are tracking your sleep for health decisions, do not rely solely on how you feel or a simple 'how many hours' question. These self-reports are often inaccurate. If precise sleep data is critical for your health management, consider using an objective tracking method like actigraphy, as subjective reports can significantly misrepresent actual sleep duration and quality.

Subjective alertness (measured by Stanford Sleepiness Scale) recovers much more slowly than objective psychomotor vigilance, with a time constant of 9.09 hours, making it appear nearly linear over typical sleep durations.

Do not rely on how sleepy you feel to judge your cognitive readiness. Subjective alertness recovers much slower (approx 9 hours to fully asymptote) than your actual ability to react and stay vigilant (approx 2 hours). You may feel subjectively 'fine' after a short nap, but your objective performance may still be recovering. For safety-critical tasks, prioritize objective rest over subjective feeling.

In patients with subjective primary insomnia (normal PSG but high sleep complaint), NREM sleep exhibits significantly lower delta power and higher alpha, sigma, and beta power compared to normal controls, reflecting heightened cortical arousal.

If you have insomnia but your sleep study shows you are getting enough sleep, your issue may be 'hyperarousal' (high brain activity) rather than 'sleep loss'. This suggests treatments targeting relaxation and reducing cortical arousal (like CBT-I) may be more effective than those simply trying to extend sleep time.

In subjective insomnia patients, diminished low-frequency (delta) and elevated high-frequency (alpha, sigma, beta) NREM EEG activity is associated with greater subjective sleep complaints and greater underestimation of sleep time.

For those who feel they get no sleep despite a normal sleep study, the problem is likely 'hyperarousal' (high brain activity) rather than 'sleep loss'. This suggests treatments targeting relaxation and reducing cortical arousal (like CBT-I) may be more effective than those simply trying to extend sleep time.

Regular consumption of low to moderate amounts of alcohol (1-99 g/day) improves insulin sensitivity, evidenced by significantly lower fasting and post-glucose insulin concentrations and reduced insulin resistance compared to abstainers.

If you drink alcohol moderately (up to ~3-4 standard drinks per day), it may help your body handle insulin better than if you abstained completely. However, this does not mean you should start drinking for health reasons, as heavy drinking has severe negative health consequences. Focus on maintaining a healthy weight and staying active, as these factors have a larger impact on insulin sensitivity than alcohol.

The energy homeostasis system is inherently biased toward weight gain because catabolic pathways are tonically active in the basal state while anabolic pathways are suppressed, making the physiological response to weight loss (activation of anabolic pathways) more vigorous than the response to weight gain (further stimulation of already-active catabolic pathways).

Understand that your body is biologically wired to defend against weight loss more aggressively than it defends against weight gain. This is not a moral failing but a physiological reality: when you lose weight, your brain actively works to restore fat stores by increasing hunger and decreasing energy expenditure. Sustainable management likely requires strategies that account for this vigorous counter-response, such as maintaining catabolic pathway activation (e.g., through specific pharmacological targets or lifestyle habits) rather than relying solely on willpower to suppress anabolic signals.

Ectopic fat deposition in the liver and pancreatic islets drives the pathogenesis of type 2 diabetes through two vicious cycles: Cycle A (hepatic) causing hepatic insulin resistance, and Cycle B (islet) causing beta-cell dysfunction.

Type 2 diabetes is driven by fat accumulating in your liver and pancreas, not just by your pancreas 'failing'. By reducing overall calorie intake, you can remove this fat and break the cycle, potentially reversing the disease if caught early.

In obese and diabetic rodent models, circulating resistin levels are elevated and positively correlated with insulin, glucose, and lipids, despite suppressed resistin mRNA expression in adipose tissue, indicating that nutritional regulation of resistin is mediated by insulin and glucose.

In obese individuals, high circulating resistin is linked to higher insulin and glucose levels, even if fat tissue gene expression is low. This suggests that managing insulin and glucose levels through diet and lifestyle may help regulate resistin, rather than focusing solely on fat mass reduction.

Leptin treatment reduces serum resistin and resistin mRNA expression in obese mice, an effect that is independent of weight loss or food intake, suggesting leptin directly regulates resistin to improve insulin sensitivity.

In obese individuals, hormonal signals like leptin may play a key role in regulating resistin levels, independent of weight loss. This suggests that improving leptin sensitivity through lifestyle changes might help normalize resistin levels.

Oral melatonin supplements have poor absolute bioavailability (approximately 15%) due to poor absorption and first-pass metabolism, whereas intravenous administration shows similar half-life but higher immediate serum peaks.

If using melatonin supplements, be aware that oral bioavailability is low (~15%). This means a significant portion is lost to metabolism. Sublingual or liquid forms may have different profiles, but standard tablets require careful dosing. Food sources provide a slower, sustained release with antioxidant benefits.

Selenium's biological activity is primarily mediated through its incorporation into selenoproteins (containing selenocysteine), which support antioxidant defense systems, thyroid hormone metabolism, and neuroprotection.

Selenium works by forming selenoproteins. Ensuring adequate intake (55 µg/day) allows your body to produce these proteins, which protect cells from oxidative stress and support thyroid and nervous system health.

Gut microbiota-derived short-chain fatty acids (SCFAs), specifically acetate, propionate, and butyrate, regulate host energy homeostasis and metabolic health by acting as signaling molecules on G-protein-coupled receptors (GPR41/43) and influencing hormone secretion (GLP-1, PYY).

To support metabolic health, prioritize diets rich in whole plant fibers. This feeds gut bacteria to produce short-chain fatty acids (SCFAs) like butyrate and acetate. These SCFAs signal your body to regulate appetite and insulin sensitivity via specific receptors, helping to prevent metabolic syndrome and obesity.

Dysbiosis, characterized by an imbalance in bacterial ratios (e.g., increased Firmicutes/Bacteroidetes ratio or decreased Akkermansia muciniphila), drives low-grade systemic inflammation and insulin resistance through the translocation of bacterial lipopolysaccharides (LPS) into the bloodstream.

Maintain gut barrier integrity to prevent metabolic inflammation. This involves avoiding factors that cause dysbiosis (like excessive antibiotics or poor diet) and supporting beneficial bacteria (like Akkermansia muciniphila) which are often depleted in obesity and diabetes.

Reduced glucose flux into adipose tissue (due to GLUT4 downregulation or knockout) triggers the secretion of Retinol-Binding Protein 4 (RBP4), which acts as a signaling molecule to induce systemic insulin resistance in muscle and liver.

In states of insulin resistance, fat cells may stop taking up glucose efficiently and instead release a protein called RBP4 that tells your muscles and liver to resist insulin. This is a biological signal, not just a passive storage issue. Managing this involves improving overall metabolic flexibility, though the paper highlights this as a pathologic mechanism in diabetes rather than a direct lifestyle intervention protocol.

Muscle-specific knockout of GLUT4 causes secondary insulin resistance in liver and adipose tissue, demonstrating that muscle glucose transport is critical for systemic insulin sensitivity.

Muscle health is crucial for overall metabolic health. Impairing glucose uptake in muscle can negatively affect how your liver and fat tissue respond to insulin. Exercise and muscle maintenance support this glucose transport mechanism.

High-dose supplementation of fat-soluble vitamins (specifically Vitamin E and beta-carotene) and Vitamin A in well-nourished adults increases the risk of adverse health outcomes, including bleeding, cancer recurrence, and all-cause mortality, rather than providing preventive health benefits.

Do not assume high-dose fat-soluble vitamin supplements (A, E) are safe just because they are vitamins. In well-nourished adults, high doses (e.g., Vitamin E >800mg/day, Beta-carotene in smokers) are linked to increased risks of bleeding, cancer recurrence, and mortality. Stick to dietary sources or standard multivitamins unless a deficiency is diagnosed by a physician.

PPAR-γ agonists reduce inflammation in macrophages and vascular cells by inhibiting NF-κB and AP-1 signaling pathways, thereby slowing atherosclerosis progression.

By reducing inflammation in your blood vessels, certain diabetes medications (TZDs) may also help protect against heart disease and plaque buildup, offering benefits beyond just blood sugar control.

Low-GI diets are not directly associated with weight reduction, despite popular belief.

Do not rely on low-GI labels alone for weight loss. While low-GI foods may help manage blood sugar, they do not guarantee weight loss. Focus on total calorie intake and overall diet quality.